Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q4 2016 · 10-K
Revenue$766.00K$766.00Kno prior Q4 2015 on file Net Income-$4.95M-$4.95MN/M vs Q4 2015 EPS Diluted-$0.17-$0.17N/M vs Q4 2015 Operating Cash Flowderived-$166,952N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
Free Cash Flowderived-$202,952N/M ended Dec 31, 2016 · filed Mar 31, 2017 · 90 d after period end